Compare · ASLE vs SNN
ASLE vs SNN
Side-by-side comparison of AerSale Corporation (ASLE) and Smith & Nephew SNATS Inc. (SNN): market cap, price performance, sector, and recent activity on the wire.
Summary
- ASLE operates in Consumer Discretionary, while SNN operates in Health Care - the two are in different parts of the market.
- SNN is the larger of the two at $13.00B, about 45.5x ASLE ($285.9M).
- Over the past year, ASLE is up 4.8% and SNN is up 1.5% - ASLE leads by 3.3 points.
- SNN has been more active in the news (7 items in the past 4 weeks vs 2 for ASLE).
- SNN has more recent analyst coverage (23 ratings vs 6 for ASLE).
- Company
- AerSale Corporation
- Smith & Nephew SNATS Inc.
- Price
- $6.04+0.17%
- $30.60-2.55%
- Market cap
- $285.9M
- $13.00B
- 1M return
- -3.75%
- +0.36%
- 1Y return
- +4.77%
- +1.48%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2019
- News (4w)
- 2
- 7
- Recent ratings
- 6
- 23
AerSale Corporation
AerSale Corporation provides aftermarket commercial aircraft, engines, and its parts to passenger and cargo airlines, leasing companies, original equipment manufacturers, and government and defense contractors, as well as maintenance, repair, and overhaul (MRO) service providers worldwide. It operates in two segments, Asset Management Solutions and Technical Operations (TechOps). The Asset Management Solutions segment engages in the sale and lease of aircraft, engines, and airframes, as well as disassembly of these assets for component parts. The TechOps segment provides internal and third-party aviation services, including internally developed engineered solutions, heavy aircraft maintenance and modification, and component MRO, as well as storage and disassembly services. This segment also provides aircraft modifications, cargo/tanker conversions of aircraft, and aircraft storage; and MRO services for landing gear, thrust reversers, hydraulic systems, and other aircraft components. The company was founded in 2008 and is headquartered in Coral Gables, Florida.
Smith & Nephew SNATS Inc.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Latest ASLE
- Officer Tschirhart Benjamin Thomas sold $505 worth of shares (77 units at $6.56) as part of a pre-agreed trading plan, decreasing direct ownership by 0.24% to 32,487 units (SEC Form 4) (withholding tax)
- B. Riley Securities initiated coverage on AerSale with a new price target
- AerSale Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Officer Pizzi Enrique sold $19,794 worth of shares (3,122 units at $6.34) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 81,224 units (SEC Form 4) (tax withholding)
- Officer Tschirhart Benjamin Thomas sold $11,958 worth of shares (1,886 units at $6.34) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 32,564 units (SEC Form 4) to satisfy withholding obligation
- Officer Jones Gary Edmund sold $47,495 worth of shares (7,491 units at $6.34) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 162,405 units (SEC Form 4) to satisfy withholding tax
- Officer Garmendia Martin sold $38,638 worth of shares (6,094 units at $6.34) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 183,377 units (SEC Form 4) (tax withholding)
- Officer Hechenberger Paul Andrew sold $10,056 worth of shares (1,586 units at $6.34) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 14,581 units (SEC Form 4) to cover withholding tax
- Officer Wright Frederick Craig sold $26,515 worth of shares (4,182 units at $6.34) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 213,531 units (SEC Form 4) (withholding tax)
- Director Nichols Robert B. was granted 19,623 shares (SEC Form 4)
Latest SNN
- Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons
- New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions
- New German expert consensus highlights role for NPWT in mitigating the economic impact of postoperative wound complications
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.